Advertisement

The Latest

Alyssa Chapital, MD, PhD, has been named vice president of Rochester, Minn.-based Mayo Clinic Health System in Wisconsin, effective Nov. 3, according to an Aug. 11 LinkedIn post. Dr. Chapital will succeed Richard Helmers, MD, who has served as vice…

Opelika-based East Alabama Health will assume management and operational oversight of Medical Center Barbour in Eufaula, Ala., beginning Oct. 1. Four things to know: 1. East Alabama Health will lead day-to-day operations and provide strategic guidance for the hospital to…

Finance skills remain the most sought-after capabilities for interim leaders and experts, according to an Aug. 12 report from executive search firm Heidrick & Struggles. The 2026 Skills Index report, shared with Becker’s, analyzed the skills most frequently requested by…

When Valhalla, N.Y.-based Westchester Medical Center Health Network recruited its chief pharmacy officer, Urshila Shah, PharmD, CEO David Lubarsky, MD, gave her an ambitious task: launch an in-house specialty pharmacy within six months. The health system met that goal. The…

Roughly 70 percent of medical decisions depend on lab results but lab spending remains one of the least scrutinized lines in a health plan’s budget. That blind spot is getting more expensive. Routine testing spend is climbing faster than the…

Presented by:

Presented by

UC San Diego Health and West Health have launched the West Health Accelerator at UC San Diego Health, a six-year, $40 million initiative to help build a new model of reliable and coordinated care that can be shared with systems…

The Cybersecurity and Infrastructure Security Agency, FBI and international partners have issued a joint advisory warning healthcare organizations about Gunra, a ransomware-as-a-service group actively targeting the sector. Gunra first emerged in April 2025 as a ransomware variant built from leaked…

AstraZeneca’s board scrapped merger talks with Bristol Myers Squibb on Aug. 3, days after reports emerged that the companies were discussing a roughly $400 billion tie-up, according to an Aug. 11 report from the Financial Times. The two companies had…

The FDA has rejected a radiopharmaceutical therapy from ITM Isotope Technologies Munich that was positioned to compete with Novartis’ leading treatments in the space. The agency issued a complete response letter for ITM-11, also known as 177Lu-edotreotide, saying it cannot…

Advertisement